Evidence map›Paper›PMID 35548629›Full record

ArticleRSC advances2018

Preparation of a novel injectable

Min Kyung Khang, Jun Zhou, Yihui Huang, Amirhossein Hakamivala, Liping Tang

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Min Kyung KhangChemistry and Biochemistry Department, University of Texas at Arlington Arlington Texas USA.ORCID 0000-0002-6497-7190
Jun ZhouBioengineering Department, University of Texas at Arlington P. O. Box 19138 Arlington Texas 76019-0138 USA ltang@uta.edu.
Yihui HuangBioengineering Department, University of Texas at Arlington P. O. Box 19138 Arlington Texas 76019-0138 USA ltang@uta.edu.
Amirhossein HakamivalaBioengineering Department, University of Texas at Arlington P. O. Box 19138 Arlington Texas 76019-0138 USA ltang@uta.edu.
Liping TangBioengineering Department, University of Texas at Arlington P. O. Box 19138 Arlington Texas 76019-0138 USA ltang@uta.edu.ORCID 0000-0002-3393-7073
The University of Texas at Arlington · USKaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temperature sensitive injectable hydrogels have been used as drug/protein carriers for a variety of pharmaceutical applications. Oligo(ethylene glycol) methacrylate (OEGMA) monomers with varying ethylene oxide chain lengths have been used for the synthesis of

Identifiers

PMID35548629
PMCPMC9087364
OpenAlexW4233942949

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.